Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study

Shohreh F. Farzan, Yu Chen, Judy R. Rees, M. Scot Zens, Margaret R. Karagas

Research output: Contribution to journalArticle

Abstract

High levels of arsenic exposure have been associated with increases in cardiovascular disease risk. However, studies of arsenic's effects at lower exposure levels are limited and few prospective studies exist in the United States using long-term arsenic exposure biomarkers. We conducted a prospective analysis of the association between toenail arsenic and cardiovascular disease mortality using longitudinal data collected on 3939 participants in the New Hampshire Skin Cancer Study. Using Cox proportional hazard models adjusted for potential confounders, we estimated hazard ratios and 95% confidence intervals associated with the risk of death from any cardiovascular disease, ischemic heart disease, and stroke, in relation to natural-log transformed toenail arsenic concentrations. In this US population, although we observed no overall association, arsenic exposure measured from toenail clipping samples was related to an increased risk of ischemic heart disease mortality among long-term smokers (as reported at baseline), with increased hazard ratios among individuals with ≥ 31 total smoking years (HR: 1.52, 95% CI: 1.02, 2.27), ≥ 30 pack-years (HR: 1.66, 95% CI: 1.12, 2.45), and among current smokers (HR: 1.69, 95% CI: 1.04, 2.75). These results are consistent with evidence from more highly exposed populations suggesting a synergistic relationship between arsenic exposure and smoking on health outcomes and support a role for lower-level arsenic exposure in ischemic heart disease mortality.

Original languageEnglish (US)
Pages (from-to)93-97
Number of pages5
JournalToxicology and Applied Pharmacology
Volume287
Issue number2
DOIs
StatePublished - Sep 1 2015

Fingerprint

Arsenic
Cardiovascular Diseases
Population
Nails
Myocardial Ischemia
Hazards
Mortality
Smoking
Association reactions
Biomarkers
Skin Neoplasms
Proportional Hazards Models
Skin
Stroke
Health
Prospective Studies
Confidence Intervals

Keywords

  • Arsenic
  • Cardiovascular disease
  • Ischemic heart disease
  • Mortality
  • New Hampshire
  • Smoking

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study. / Farzan, Shohreh F.; Chen, Yu; Rees, Judy R.; Zens, M. Scot; Karagas, Margaret R.

In: Toxicology and Applied Pharmacology, Vol. 287, No. 2, 01.09.2015, p. 93-97.

Research output: Contribution to journalArticle

@article{53c7b7fa2ed64f0fbd3749f798284251,
title = "Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study",
abstract = "High levels of arsenic exposure have been associated with increases in cardiovascular disease risk. However, studies of arsenic's effects at lower exposure levels are limited and few prospective studies exist in the United States using long-term arsenic exposure biomarkers. We conducted a prospective analysis of the association between toenail arsenic and cardiovascular disease mortality using longitudinal data collected on 3939 participants in the New Hampshire Skin Cancer Study. Using Cox proportional hazard models adjusted for potential confounders, we estimated hazard ratios and 95{\%} confidence intervals associated with the risk of death from any cardiovascular disease, ischemic heart disease, and stroke, in relation to natural-log transformed toenail arsenic concentrations. In this US population, although we observed no overall association, arsenic exposure measured from toenail clipping samples was related to an increased risk of ischemic heart disease mortality among long-term smokers (as reported at baseline), with increased hazard ratios among individuals with ≥ 31 total smoking years (HR: 1.52, 95{\%} CI: 1.02, 2.27), ≥ 30 pack-years (HR: 1.66, 95{\%} CI: 1.12, 2.45), and among current smokers (HR: 1.69, 95{\%} CI: 1.04, 2.75). These results are consistent with evidence from more highly exposed populations suggesting a synergistic relationship between arsenic exposure and smoking on health outcomes and support a role for lower-level arsenic exposure in ischemic heart disease mortality.",
keywords = "Arsenic, Cardiovascular disease, Ischemic heart disease, Mortality, New Hampshire, Smoking",
author = "Farzan, {Shohreh F.} and Yu Chen and Rees, {Judy R.} and Zens, {M. Scot} and Karagas, {Margaret R.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.taap.2015.05.013",
language = "English (US)",
volume = "287",
pages = "93--97",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study

AU - Farzan, Shohreh F.

AU - Chen, Yu

AU - Rees, Judy R.

AU - Zens, M. Scot

AU - Karagas, Margaret R.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - High levels of arsenic exposure have been associated with increases in cardiovascular disease risk. However, studies of arsenic's effects at lower exposure levels are limited and few prospective studies exist in the United States using long-term arsenic exposure biomarkers. We conducted a prospective analysis of the association between toenail arsenic and cardiovascular disease mortality using longitudinal data collected on 3939 participants in the New Hampshire Skin Cancer Study. Using Cox proportional hazard models adjusted for potential confounders, we estimated hazard ratios and 95% confidence intervals associated with the risk of death from any cardiovascular disease, ischemic heart disease, and stroke, in relation to natural-log transformed toenail arsenic concentrations. In this US population, although we observed no overall association, arsenic exposure measured from toenail clipping samples was related to an increased risk of ischemic heart disease mortality among long-term smokers (as reported at baseline), with increased hazard ratios among individuals with ≥ 31 total smoking years (HR: 1.52, 95% CI: 1.02, 2.27), ≥ 30 pack-years (HR: 1.66, 95% CI: 1.12, 2.45), and among current smokers (HR: 1.69, 95% CI: 1.04, 2.75). These results are consistent with evidence from more highly exposed populations suggesting a synergistic relationship between arsenic exposure and smoking on health outcomes and support a role for lower-level arsenic exposure in ischemic heart disease mortality.

AB - High levels of arsenic exposure have been associated with increases in cardiovascular disease risk. However, studies of arsenic's effects at lower exposure levels are limited and few prospective studies exist in the United States using long-term arsenic exposure biomarkers. We conducted a prospective analysis of the association between toenail arsenic and cardiovascular disease mortality using longitudinal data collected on 3939 participants in the New Hampshire Skin Cancer Study. Using Cox proportional hazard models adjusted for potential confounders, we estimated hazard ratios and 95% confidence intervals associated with the risk of death from any cardiovascular disease, ischemic heart disease, and stroke, in relation to natural-log transformed toenail arsenic concentrations. In this US population, although we observed no overall association, arsenic exposure measured from toenail clipping samples was related to an increased risk of ischemic heart disease mortality among long-term smokers (as reported at baseline), with increased hazard ratios among individuals with ≥ 31 total smoking years (HR: 1.52, 95% CI: 1.02, 2.27), ≥ 30 pack-years (HR: 1.66, 95% CI: 1.12, 2.45), and among current smokers (HR: 1.69, 95% CI: 1.04, 2.75). These results are consistent with evidence from more highly exposed populations suggesting a synergistic relationship between arsenic exposure and smoking on health outcomes and support a role for lower-level arsenic exposure in ischemic heart disease mortality.

KW - Arsenic

KW - Cardiovascular disease

KW - Ischemic heart disease

KW - Mortality

KW - New Hampshire

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=84938987119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938987119&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2015.05.013

DO - 10.1016/j.taap.2015.05.013

M3 - Article

C2 - 26048586

AN - SCOPUS:84938987119

VL - 287

SP - 93

EP - 97

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 2

ER -